Profound Sinoatrial Arrest Associated with Ibrutinib

BACKGROUNDIbrutinib is a Bruton's tyrosine kinase (BTK) inhibitor approved for second-line treatment for mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenström macroglobulinemia. Ibrutinib use has been linked to increased incidence of atrial fibrillation and hypertensio...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Case reports in oncological medicine 2017, Vol.2017, p.7304021-7304021
Hauptverfasser:	Mathur, Kanupriya, Saini, Aditya, Ellenbogen, Kenneth A, Shepard, Richard K
Format:	Report
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!